SYNH Insider Trading Activity and SEC Form 4 Filings
SYNH insider trading summary
No open-market insider purchases or sales of Syneos Health, Inc. (SYNH) have been reported on SEC Form 4 in the past 12 months.
Latest SYNH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 28, 2022 | Michael Lee Brooks | Chief Operating Officer | Sell | $39K (500 @ $78.00) |
| Jul 28, 2022 | Michael Lee Brooks | Chief Operating Officer | Sell | $78K (1,002 @ $78.00) |
| Jul 21, 2022 | Michael Lee Brooks | Chief Operating Officer | Sell | $38K (500 @ $76.00) |
| Jul 21, 2022 | Michael Lee Brooks | Chief Operating Officer | Sell | $76K (1,002 @ $76.00) |
| Jul 20, 2022 | Jonathan Olefson | General Counsel & Corp Secty | Sell | $166K (2,215 @ $75.00) |
| Jul 19, 2022 | Michael Lee Brooks | Chief Operating Officer | Sell | $74K (1,002 @ $74.00) |
| Jul 19, 2022 | Michael Lee Brooks | Chief Operating Officer | Sell | $37K (500 @ $74.00) |
| Jul 18, 2022 | Jason M. Meggs | Chief Financial Officer | Sell | $546K (7,500 @ $72.81) |
| Jul 18, 2022 | Michelle Keefe | Chief Executive Officer | Sell | $607K (8,333 @ $72.81) |
| Jul 8, 2022 | Donna Hildebrand Kralowetz | EVP, Chief Accounting Officer | Sell | $84K (1,149 @ $73.16) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.